Yongjin Park

I am the co-founder and CSO of 1849 bio. I studied chemical engineering at KAIST and did my PhD at MIT in the Department of Biological Engineering. During my PhD, I developed core technology used in the world's first engineered probiotic that went into clinical trial. After completing PhD, I worked in deep biotech companies, developing microbial products that were administered to over 6M acres of farmland in the US (about the area of Belgium!).